Canadian researchers have developed “smart textiles” able to monitor and transmit wearers’ biomedical information via wireless or cellular network by superimposing multiple layers of copper, polymers, glass, and silver.
GI View out of Ramat Gan, Israel finally won FDA clearance to introduce to the U.S. market its self-propelled single-use Aer-O-Scope colonoscope. This device originally appeared on our radar almost a decade ago, but the regulatory road seems to have been rocky for GI View, and the company expects it will be at least another year before it begins introducing the Aer-O-Scope to the U.S. market.
I was asked by the U.S.-UK Fulbright Commission to give a series of lectures in the United Kingdom in 2013 on the topic of diplomacy. This was surprising, as I am even marginally competent in only one domain of diplomacy—the forms of international relations that involve nations working together in fields of medical science and health. So I proposed to address the question of what accounted for the success—despite inherent difficulties and adverse circumstances—of three important and ambitious international initiatives in medicine and related science undertaken by the United States.
Tom Telford ’s stomach ached. The New York City teacher had been drinking cup after cup of coffee as he labored to finish year-end grading and coach his high-school baseball team through the playoffs. He worried he might have an ulcer.
Health startup founders have one more day to get their applications in to be a part of DreamIt Health’s second Baltimore cohort.
The deadline is Friday for the new group of health startups. Get to it.
BioCity, the Bioscience incubation specialist with locations in the East Midlands (BioCity and Medicity in Nottingham), the North West (BioHub at Alderley Park) and Scotland (BioCity Scotland at Newhouse), has announced a new investment fund, created following a significant contribution by AstraZeneca.
Swiss pharmaceutical giant Roche Holdings (NASDAQ:RHHBY) recently announced the acquisition of Ariosa Diagnostics, which makes non-invasive prenatal testing equipment. The terms of the deal were not disclosed by Roche in its press release. According to WHO, there are over 200 million pregnancies worldwide annually and prenatal testing to detect Down syndrome is gaining strong traction.
Entrepreneurs on college campuses got another boost Thursday with Boston-area Xfund closing a $100 million fund to bankroll new ideas and support startups it’s backed so far.
The recent bumpy landing of Philae on comet 67P/Churyumov-Gerasimenko after a ten year journey, and more than 1.4 billion euros in investment, is a fantastic example of European science, expertise and collaboration at work.
Biopharmaceuticals are among the most sophisticated and elegant achievements of modern science. The huge, complex structures of these drugs don’t just look extraordinary in the 3-D modeling systems used to design them; they also perform their jobs remarkably well, offering high efficacy and few side effects. And there is much more to come: existing treatment archetypes are evolving and becoming more sophisticated all the time, and continuing research is yielding entirely new types of products.